The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

What Biomarkers, Tumor- and Immune- Centric Mechanisms Underpin Clinical Response in CSCC?


Published

December 26, 2018

Created by

CMEducation Resources symposium

Related Presenters

Sunandana Chandra, MD, MS

Sunandana Chandra, MD, MS

Assistant Professor, Division of Hematology Oncology Robert H. Lurie Comprehensive Cancer Center Northwestern University